• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Yonezawa Honami  米澤 穂波

ORCIDConnect your ORCID iD *help
Researcher Number 90963364
Other IDs
Affiliation (Current) 2025: 岩手医科大学, 薬学部, 助教
Affiliation (based on the past Project Information) *help 2022 – 2024: 岩手医科大学, 薬学部, 助教
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / 0901:Oncology and related fields
Keywords
Principal Investigator
小児がん / 阻害剤 / ユーイング肉腫 / イベルメクチン / TELO2 / 悪性ラブドイド腫瘍
  • Research Projects

    (2 results)
  • Research Products

    (7 results)
  •  TELO2機能阻害による合成致死誘導に基づく転移性ユーイング肉腫治療の基盤形成Principal Investigator

    • Principal Investigator
      米澤 穂波
    • Project Period (FY)
      2024 – 2026
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Iwate Medical University
  •  TELO2-targeting therapy for SMARCB1-deficient malignant rhabdoid tumorPrincipal Investigator

    • Principal Investigator
      Yonezawa Honami
    • Project Period (FY)
      2022 – 2023
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0901:Oncology and related fields
    • Research Institution
      Iwate Medical University

All 2024 2023

All Presentation

  • [Presentation] イベルメクチン結合因子の同定とWnt/β-catenin経路制御機能の解析2024

    • Author(s)
      米澤穂波、大森紀和、池田朱里、廣瀬友靖、岩月正人、砂塚敏明、上原至雅、西谷直之
    • Organizer
      日本薬学会第144年会
    • Data Source
      KAKENHI-PROJECT-22K20800
  • [Presentation] PIKKs安定化因子TELO2の機能抑制は悪性ラブドイド腫瘍細胞の増殖を阻害する2024

    • Author(s)
      米澤 穂波、氏家 悠貴、上原 至雅、西谷 直之
    • Organizer
      第28回日本がん分子標的治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K20800
  • [Presentation] PIKKs安定化因子TELO2はイベルメクチンによる Wnt/β-catenin経路阻害作用を仲介する2023

    • Author(s)
      米澤穂波、池田朱里、高橋亮、廣瀬友靖、岩月正人、砂塚敏明、上原至雅、西谷直之
    • Organizer
      日本薬学会第143年会
    • Data Source
      KAKENHI-PROJECT-22K20800
  • [Presentation] A chemical suppressor screening in zebrafish identifies Wnt/β-catenin pathway inhibitors improving anticancer drug response.2023

    • Author(s)
      Naoyuki Nishiya, Honami Yonezawa
    • Organizer
      EACR conference Cellular Bases for Patient Response to Cancer Therapies
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K20800
  • [Presentation] TELO2, a regulator of phosphatidylinositol 3-kinase-related kinases, is a druggable target for an inhibitor of the Wnt/β-catenin and the mTOR signaling2023

    • Author(s)
      Honami Yonezawa, Haruki Ujiie, Yoshimasa Uehara, Naoyuki Nishiya
    • Organizer
      EACR conference Cellular Bases for Patient Response to Cancer Therapies
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-22K20800
  • [Presentation] PIKKs安定化因子TELO2の機能制御による悪性ラブドイド腫瘍細胞の増殖抑制2023

    • Author(s)
      米澤 穂波、上原 至雅、西谷 直之
    • Organizer
      第27回日本がん分子標的治療学会学術集会
    • Data Source
      KAKENHI-PROJECT-22K20800
  • [Presentation] Suppression of TELO2 inhibits survival of malignant rhabdoid tumor cells2023

    • Author(s)
      Honami Yonezawa, Haruki Ujiie, Yoshimasa Uehara, Naoyuki Nishiya
    • Organizer
      第82回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-22K20800

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi